Clinical Trials in Nashville

Showing 3861-3880 of 20,298 trials

Multicenter Assessment of the Pancreas in Type 1 Diabetes

NCT03585153

The overall goal of this research is to develop and validate standard operating procedures (SOP) to assess the human pancreas in individuals with type 1 diabetes (T1D) and other forms of diabetes using advanced, quantitative magnetic resonance imaging (MRI) approaches.

Diabetes Mellitus

Vanderbilt University Medical Center250 participantsStarted Feb 2014

Aurora, Colorado, United States • Chicago, Illinois, United States • Nashville, Tennessee, United States +2 more locations

Active Not RecruitingPhase 39.2 miles

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT05882877

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Atopic Dermatitis

Amgen2,621 participantsStarted May 2023

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +544 more locations

Multicenter Assessment of the Pancreas in Type 1 Diabetes

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Find Trials by Condition in Nashville

Neuspera's Implantable Sacral Nerve Stimulation System in Patients With Symptoms of Urinary Urgency Incontinence (UUI)

Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Zilebesiran as Add-on Therapy in Patients With Hypertension Not Adequately Controlled by a Standard of Care Antihypertensive Medication (KARDIA-2)

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

ALTERRA Post-Approval Study

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)

ZILRETTA in Subjects With Shoulder Osteoarthritis

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Selinexor, Carfilzomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

A Modular Phase 1/2 Study With CT7439 in Participants With Solid Malignancies

DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas

SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease

Ca-Mg Butyrate in GWI